Antiretroviral Therapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 72 pages | ID: AB038553EE32EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antiretroviral Therapy in global, including the following market information:

Global Antiretroviral Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antiretroviral Therapy Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Antiretroviral Therapy companies in 2021 (%)

The global Antiretroviral Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

NNRTIs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antiretroviral Therapy include Gilead, F. Hoffmann-La Roche, ViiV Healthcare, Boehringer Ingelheim, Janssen Pharmaceuticals, Mylan, Abbvie, Bionor Pharma and Vertex Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antiretroviral Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antiretroviral Therapy Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Antiretroviral Therapy Market Segment Percentages, by Type, 2021 (%)

• NNRTIs
• NRTI
• Multiclass Combination Products
• Integrase Inhibitors

Global Antiretroviral Therapy Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Antiretroviral Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Antiretroviral Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Antiretroviral Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antiretroviral Therapy revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antiretroviral Therapy revenues share in global market, 2021 (%)

Key companies Antiretroviral Therapy sales in global market, 2017-2022 (Estimated), (KG)

Key companies Antiretroviral Therapy sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead
• F. Hoffmann-La Roche
• ViiV Healthcare
• Boehringer Ingelheim
• Janssen Pharmaceuticals
• Mylan
• Abbvie
• Bionor Pharma
• Vertex Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antiretroviral Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antiretroviral Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIRETROVIRAL THERAPY OVERALL MARKET SIZE

2.1 Global Antiretroviral Therapy Market Size: 2021 VS 2028
2.2 Global Antiretroviral Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antiretroviral Therapy Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Antiretroviral Therapy Players in Global Market
3.2 Top Global Antiretroviral Therapy Companies Ranked by Revenue
3.3 Global Antiretroviral Therapy Revenue by Companies
3.4 Global Antiretroviral Therapy Sales by Companies
3.5 Global Antiretroviral Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antiretroviral Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antiretroviral Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiretroviral Therapy Players in Global Market
  3.8.1 List of Global Tier 1 Antiretroviral Therapy Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antiretroviral Therapy Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antiretroviral Therapy Market Size Markets, 2021 & 2028
  4.1.2 NNRTIs
  4.1.3 NRTI
  4.1.4 Multiclass Combination Products
  4.1.5 Integrase Inhibitors
4.2 By Type - Global Antiretroviral Therapy Revenue & Forecasts
  4.2.1 By Type - Global Antiretroviral Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Antiretroviral Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Antiretroviral Therapy Sales & Forecasts
  4.3.1 By Type - Global Antiretroviral Therapy Sales, 2017-2022
  4.3.2 By Type - Global Antiretroviral Therapy Sales, 2023-2028
  4.3.3 By Type - Global Antiretroviral Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Antiretroviral Therapy Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antiretroviral Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Antiretroviral Therapy Revenue & Forecasts
  5.2.1 By Application - Global Antiretroviral Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Antiretroviral Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Antiretroviral Therapy Sales & Forecasts
  5.3.1 By Application - Global Antiretroviral Therapy Sales, 2017-2022
  5.3.2 By Application - Global Antiretroviral Therapy Sales, 2023-2028
  5.3.3 By Application - Global Antiretroviral Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Antiretroviral Therapy Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antiretroviral Therapy Market Size, 2021 & 2028
6.2 By Region - Global Antiretroviral Therapy Revenue & Forecasts
  6.2.1 By Region - Global Antiretroviral Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Antiretroviral Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Antiretroviral Therapy Sales & Forecasts
  6.3.1 By Region - Global Antiretroviral Therapy Sales, 2017-2022
  6.3.2 By Region - Global Antiretroviral Therapy Sales, 2023-2028
  6.3.3 By Region - Global Antiretroviral Therapy Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Antiretroviral Therapy Revenue, 2017-2028
  6.4.2 By Country - North America Antiretroviral Therapy Sales, 2017-2028
  6.4.3 US Antiretroviral Therapy Market Size, 2017-2028
  6.4.4 Canada Antiretroviral Therapy Market Size, 2017-2028
  6.4.5 Mexico Antiretroviral Therapy Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Antiretroviral Therapy Revenue, 2017-2028
  6.5.2 By Country - Europe Antiretroviral Therapy Sales, 2017-2028
  6.5.3 Germany Antiretroviral Therapy Market Size, 2017-2028
  6.5.4 France Antiretroviral Therapy Market Size, 2017-2028
  6.5.5 U.K. Antiretroviral Therapy Market Size, 2017-2028
  6.5.6 Italy Antiretroviral Therapy Market Size, 2017-2028
  6.5.7 Russia Antiretroviral Therapy Market Size, 2017-2028
  6.5.8 Nordic Countries Antiretroviral Therapy Market Size, 2017-2028
  6.5.9 Benelux Antiretroviral Therapy Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Antiretroviral Therapy Revenue, 2017-2028
  6.6.2 By Region - Asia Antiretroviral Therapy Sales, 2017-2028
  6.6.3 China Antiretroviral Therapy Market Size, 2017-2028
  6.6.4 Japan Antiretroviral Therapy Market Size, 2017-2028
  6.6.5 South Korea Antiretroviral Therapy Market Size, 2017-2028
  6.6.6 Southeast Asia Antiretroviral Therapy Market Size, 2017-2028
  6.6.7 India Antiretroviral Therapy Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Antiretroviral Therapy Revenue, 2017-2028
  6.7.2 By Country - South America Antiretroviral Therapy Sales, 2017-2028
  6.7.3 Brazil Antiretroviral Therapy Market Size, 2017-2028
  6.7.4 Argentina Antiretroviral Therapy Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antiretroviral Therapy Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Antiretroviral Therapy Sales, 2017-2028
  6.8.3 Turkey Antiretroviral Therapy Market Size, 2017-2028
  6.8.4 Israel Antiretroviral Therapy Market Size, 2017-2028
  6.8.5 Saudi Arabia Antiretroviral Therapy Market Size, 2017-2028
  6.8.6 UAE Antiretroviral Therapy Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Gilead
  7.1.1 Gilead Corporate Summary
  7.1.2 Gilead Business Overview
  7.1.3 Gilead Antiretroviral Therapy Major Product Offerings
  7.1.4 Gilead Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.1.5 Gilead Key News
7.2 F. Hoffmann-La Roche
  7.2.1 F. Hoffmann-La Roche Corporate Summary
  7.2.2 F. Hoffmann-La Roche Business Overview
  7.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.2.5 F. Hoffmann-La Roche Key News
7.3 ViiV Healthcare
  7.3.1 ViiV Healthcare Corporate Summary
  7.3.2 ViiV Healthcare Business Overview
  7.3.3 ViiV Healthcare Antiretroviral Therapy Major Product Offerings
  7.3.4 ViiV Healthcare Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.3.5 ViiV Healthcare Key News
7.4 Boehringer Ingelheim
  7.4.1 Boehringer Ingelheim Corporate Summary
  7.4.2 Boehringer Ingelheim Business Overview
  7.4.3 Boehringer Ingelheim Antiretroviral Therapy Major Product Offerings
  7.4.4 Boehringer Ingelheim Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.4.5 Boehringer Ingelheim Key News
7.5 Janssen Pharmaceuticals
  7.5.1 Janssen Pharmaceuticals Corporate Summary
  7.5.2 Janssen Pharmaceuticals Business Overview
  7.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Major Product Offerings
  7.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.5.5 Janssen Pharmaceuticals Key News
7.6 Mylan
  7.6.1 Mylan Corporate Summary
  7.6.2 Mylan Business Overview
  7.6.3 Mylan Antiretroviral Therapy Major Product Offerings
  7.6.4 Mylan Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.6.5 Mylan Key News
7.7 Abbvie
  7.7.1 Abbvie Corporate Summary
  7.7.2 Abbvie Business Overview
  7.7.3 Abbvie Antiretroviral Therapy Major Product Offerings
  7.7.4 Abbvie Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.7.5 Abbvie Key News
7.8 Bionor Pharma
  7.8.1 Bionor Pharma Corporate Summary
  7.8.2 Bionor Pharma Business Overview
  7.8.3 Bionor Pharma Antiretroviral Therapy Major Product Offerings
  7.8.4 Bionor Pharma Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.8.5 Bionor Pharma Key News
7.9 Vertex Pharmaceuticals
  7.9.1 Vertex Pharmaceuticals Corporate Summary
  7.9.2 Vertex Pharmaceuticals Business Overview
  7.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Major Product Offerings
  7.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Sales and Revenue in Global (2017-2022)
  7.9.5 Vertex Pharmaceuticals Key News

8 GLOBAL ANTIRETROVIRAL THERAPY PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antiretroviral Therapy Production Capacity, 2017-2028
8.2 Antiretroviral Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Antiretroviral Therapy Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTIRETROVIRAL THERAPY SUPPLY CHAIN ANALYSIS

10.1 Antiretroviral Therapy Industry Value Chain
10.2 Antiretroviral Therapy Upstream Market
10.3 Antiretroviral Therapy Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antiretroviral Therapy Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antiretroviral Therapy in Global Market
Table 2. Top Antiretroviral Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antiretroviral Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antiretroviral Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Antiretroviral Therapy Sales by Companies, (KG), 2017-2022
Table 6. Global Antiretroviral Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antiretroviral Therapy Price (2017-2022) & (USD/KG)
Table 8. Global Manufacturers Antiretroviral Therapy Product Type
Table 9. List of Global Tier 1 Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiretroviral Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antiretroviral Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antiretroviral Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antiretroviral Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antiretroviral Therapy Sales (KG), 2017-2022
Table 15. By Type - Global Antiretroviral Therapy Sales (KG), 2023-2028
Table 16. By Application – Global Antiretroviral Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antiretroviral Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antiretroviral Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antiretroviral Therapy Sales (KG), 2017-2022
Table 20. By Application - Global Antiretroviral Therapy Sales (KG), 2023-2028
Table 21. By Region – Global Antiretroviral Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antiretroviral Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antiretroviral Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antiretroviral Therapy Sales (KG), 2017-2022
Table 25. By Region - Global Antiretroviral Therapy Sales (KG), 2023-2028
Table 26. By Country - North America Antiretroviral Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antiretroviral Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antiretroviral Therapy Sales, (KG), 2017-2022
Table 29. By Country - North America Antiretroviral Therapy Sales, (KG), 2023-2028
Table 30. By Country - Europe Antiretroviral Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antiretroviral Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antiretroviral Therapy Sales, (KG), 2017-2022
Table 33. By Country - Europe Antiretroviral Therapy Sales, (KG), 2023-2028
Table 34. By Region - Asia Antiretroviral Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antiretroviral Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antiretroviral Therapy Sales, (KG), 2017-2022
Table 37. By Region - Asia Antiretroviral Therapy Sales, (KG), 2023-2028
Table 38. By Country - South America Antiretroviral Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antiretroviral Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antiretroviral Therapy Sales, (KG), 2017-2022
Table 41. By Country - South America Antiretroviral Therapy Sales, (KG), 2023-2028
Table 42. By Country - Middle East & Africa Antiretroviral Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antiretroviral Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antiretroviral Therapy Sales, (KG), 2017-2022
Table 45. By Country - Middle East & Africa Antiretroviral Therapy Sales, (KG), 2023-2028
Table 46. Gilead Corporate Summary
Table 47. Gilead Antiretroviral Therapy Product Offerings
Table 48. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 49. F. Hoffmann-La Roche Corporate Summary
Table 50. F. Hoffmann-La Roche Antiretroviral Therapy Product Offerings
Table 51. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 52. ViiV Healthcare Corporate Summary
Table 53. ViiV Healthcare Antiretroviral Therapy Product Offerings
Table 54. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 55. Boehringer Ingelheim Corporate Summary
Table 56. Boehringer Ingelheim Antiretroviral Therapy Product Offerings
Table 57. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 58. Janssen Pharmaceuticals Corporate Summary
Table 59. Janssen Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 60. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 61. Mylan Corporate Summary
Table 62. Mylan Antiretroviral Therapy Product Offerings
Table 63. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 64. Abbvie Corporate Summary
Table 65. Abbvie Antiretroviral Therapy Product Offerings
Table 66. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 67. Bionor Pharma Corporate Summary
Table 68. Bionor Pharma Antiretroviral Therapy Product Offerings
Table 69. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 70. Vertex Pharmaceuticals Corporate Summary
Table 71. Vertex Pharmaceuticals Antiretroviral Therapy Product Offerings
Table 72. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$, Mn) and Average Price (USD/KG) (2017-2022)
Table 73. Antiretroviral Therapy Production Capacity (KG) of Key Manufacturers in Global Market, 2020-2022 (KG)
Table 74. Global Antiretroviral Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Antiretroviral Therapy Production by Region, 2017-2022 (KG)
Table 76. Global Antiretroviral Therapy Production by Region, 2023-2028 (KG)
Table 77. Antiretroviral Therapy Market Opportunities & Trends in Global Market
Table 78. Antiretroviral Therapy Market Drivers in Global Market
Table 79. Antiretroviral Therapy Market Restraints in Global Market
Table 80. Antiretroviral Therapy Raw Materials
Table 81. Antiretroviral Therapy Raw Materials Suppliers in Global Market
Table 82. Typical Antiretroviral Therapy Downstream
Table 83. Antiretroviral Therapy Downstream Clients in Global Market
Table 84. Antiretroviral Therapy Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Antiretroviral Therapy Segment by Type
Figure 2. Antiretroviral Therapy Segment by Application
Figure 3. Global Antiretroviral Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antiretroviral Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antiretroviral Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Antiretroviral Therapy Sales in Global Market: 2017-2028 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Antiretroviral Therapy Revenue in 2021
Figure 9. By Type - Global Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antiretroviral Therapy Price (USD/KG), 2017-2028
Figure 12. By Application - Global Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antiretroviral Therapy Price (USD/KG), 2017-2028
Figure 15. By Region - Global Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 19. US Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 24. Germany Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 33. China Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antiretroviral Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antiretroviral Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antiretroviral Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antiretroviral Therapy Production Capacity (KG), 2017-2028
Figure 49. The Percentage of Production Antiretroviral Therapy by Region, 2021 VS 2028
Figure 50. Antiretroviral Therapy Industry Value Chain
Figure 51. Marketing Channels